Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose allopurinol crossover with thiopurines in inflammatory bowel disease
NL-OMON42907Active, not recruiting
- Sponsor
- Meander Medical Center
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of allopurinol, azathioprine and mercaptopurine in Crohn's disease, autoimmune colitis and inflammatory bowel disease (IBD), sponsored by Meander Medical Center. Primary endpoints: 6-TGN concentration and 6-MMP concentration. Started Sep 2016; status: active, not recruiting.
02
Drugs
allopurinolazathioprinemercaptopurine
03
Conditions
Crohn's diseaseautoimmune colitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON42907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42907.